Resony Health is a pioneering digital therapeutic company founded in 2020. The company's mission is to deliver instant access to affordable and evidence-based digital therapy to people all over the world. Resony offers an evidence-based, UKCA-marked self-management platform for common mental health conditions. Their Slogan "Delivering instant access to affordable and evidence-based digital therapy to people all over the world" encapsulates their core vision. The company operates in the Health Care and Mobile industries from its headquarters in the United Kingdom.
Resony's innovative approach focuses on empowering individuals to take control of their wellbeing through engaging and clinically-proven digital tools. Their platform not only provides engaging digital therapy but also enhances the capacity for the NHS to reach and support more patients while providing support for clinical staff. Resony's commitment to patient outcomes and value-based care is reflected in their shared risk model with the NHS, transparent pricing based on usage, and patient outcomes.
Although the specific details about their last investment and investors are currently unavailable, Resony Health's focus on revolutionizing mental health care and making a meaningful difference in the lives of countless individuals presents an intriguing proposition for potential investors. The company's innovative approach and alignment with the evolving landscape of mental health services make it worthy of consideration in the health tech and digital therapy investment space.